Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.032x

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) has a cash flow conversion efficiency ratio of 0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥88.11 Million ≈ $12.89 Million USD) by net assets (CN¥2.73 Billion ≈ $399.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2009–2024)

Cash flow conversion efficiency of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd from 2009 to 2024. This chart illustrates how Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Zhejiang Wolwo Bio-Pharmaceutical Co Ltd stock price for real-time trading data and today's change.

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Zhejiang Wolwo Bio-Pharmaceutical Co Ltd stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Concentrix Corporation
NASDAQ:CNXC
0.095x
Pimco Dynamic Income Opportunities Fund
NYSE:PDO
0.276x
REMEGEN CO. LTD YC 1
F:REG
N/A
Photronics Inc
NASDAQ:PLAB
0.044x
Mister Car Wash, Inc. Common Stock
NYSE:MCW
0.083x
Triumph Science & Technology Co Ltd
SHG:600552
-0.015x
Shenzhen Agricultural Products Co Ltd
SHE:000061
0.001x
Douglas Emmett Inc
NYSE:DEI
0.040x

Annual Cash Flow Conversion Efficiency for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd from 2009 to 2024. Review 300357 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.46 Billion
≈ $359.80 Million
CN¥262.44 Million
≈ $38.40 Million
0.107x -36.68%
2023-12-31 CN¥2.30 Billion
≈ $337.10 Million
CN¥388.32 Million
≈ $56.82 Million
0.169x -5.16%
2022-12-31 CN¥2.03 Billion
≈ $296.63 Million
CN¥360.28 Million
≈ $52.72 Million
0.178x -11.44%
2021-12-31 CN¥1.80 Billion
≈ $262.90 Million
CN¥360.58 Million
≈ $52.76 Million
0.201x +19.70%
2020-12-31 CN¥1.53 Billion
≈ $223.62 Million
CN¥256.22 Million
≈ $37.49 Million
0.168x -2.68%
2019-12-31 CN¥1.35 Billion
≈ $197.83 Million
CN¥232.93 Million
≈ $34.08 Million
0.172x -16.93%
2018-12-31 CN¥995.42 Million
≈ $145.66 Million
CN¥206.45 Million
≈ $30.21 Million
0.207x +4.43%
2017-12-31 CN¥801.26 Million
≈ $117.25 Million
CN¥159.13 Million
≈ $23.29 Million
0.199x +6.05%
2016-12-31 CN¥655.58 Million
≈ $95.93 Million
CN¥122.77 Million
≈ $17.97 Million
0.187x -4.93%
2015-12-31 CN¥582.91 Million
≈ $85.30 Million
CN¥114.82 Million
≈ $16.80 Million
0.197x +20.85%
2014-12-31 CN¥513.55 Million
≈ $75.15 Million
CN¥83.70 Million
≈ $12.25 Million
0.163x -29.58%
2013-12-31 CN¥251.92 Million
≈ $36.86 Million
CN¥58.30 Million
≈ $8.53 Million
0.231x +1.97%
2012-12-31 CN¥181.38 Million
≈ $26.54 Million
CN¥41.17 Million
≈ $6.02 Million
0.227x +51.24%
2011-12-31 CN¥127.61 Million
≈ $18.67 Million
CN¥19.15 Million
≈ $2.80 Million
0.150x -6.64%
2010-12-31 CN¥90.44 Million
≈ $13.23 Million
CN¥14.54 Million
≈ $2.13 Million
0.161x +42.42%
2009-12-31 CN¥111.89 Million
≈ $16.37 Million
CN¥12.63 Million
≈ $1.85 Million
0.113x --

About Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

SHE:300357 China Drug Manufacturers - General
Market Cap
$1.65 Billion
CN¥11.28 Billion CNY
Market Cap Rank
#6599 Global
#1271 in China
Share Price
CN¥21.55
Change (1 day)
+0.05%
52-Week Range
CN¥18.87 - CN¥33.65
All Time High
CN¥5101.55
About

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; and Changdian, a dust mite skin prick diagnost… Read more